These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 944514)

  • 1. [The effectiveness of amantadine (midantan) in the treatment of the parkinsonian syndrome].
    Kadykov AS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(2):174-8. PubMed ID: 944514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs].
    Evtushenko SK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Dec; 76(12):1797-1802. PubMed ID: 1015115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
    [No Abstract]   [Full Text] [Related]  

  • 4. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S; Nagaswami R
    Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
    [No Abstract]   [Full Text] [Related]  

  • 5. [Catecholamine excretion and treatment of parkinsonism with midantan].
    Kandel' EI; Iadgarov IS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1323-6. PubMed ID: 1015136
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism].
    Man'kovskii NB; Vainshtok AB; Oleinik LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of the Parkinson syndrome with amantadine].
    Hartmann-von Monakow K
    Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trans-cerebral electrophoresis of L-DOPA in the complex treatment of parkinsonism].
    Neĭmark EZ; Evtushenko SK; Dukhovnaia MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1334-8. PubMed ID: 6506979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of the Soviet preparation midantan in the treatment of the Parkinsonian syndrome].
    Balunov OA; Bazhin EF; Morozova ES; Fedotenkova TN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(8):1178-81. PubMed ID: 4417237
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with the use of parlodel in the treatment of Parkinson patients].
    Stoliarova LG; Kadykov AS; Shvedkov VV; Pivovarova VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):219-22. PubMed ID: 3705825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-year treatment of patients with parkinsonism using amantadine alone or with levodopa.
    Timberlake WH; Vance MA
    Ann Neurol; 1978 Feb; 3(2):119-28. PubMed ID: 350129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Parkinsonian syndrome using amantadine hydrochloride].
    Schubert U; Fischer GJ; Glass J
    Z Arztl Fortbild (Jena); 1975 May; 69(9):469-76. PubMed ID: 1106004
    [No Abstract]   [Full Text] [Related]  

  • 13. Twenty-five years of amantadine therapy in Parkinson's disease.
    Danielczyk W
    J Neural Transm Suppl; 1995; 46():399-405. PubMed ID: 8821075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
    Parkes JD; Baxter RC; Marsden CD; Rees JE
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
    Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K
    No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522
    [No Abstract]   [Full Text] [Related]  

  • 16. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center].
    Antonini FM; Baroni A
    Minerva Med; 1971 Oct; 62(82):4027-30. PubMed ID: 5125072
    [No Abstract]   [Full Text] [Related]  

  • 17. [The antiparkinson activity of gludantan (preliminary report)].
    Kamianov IM; Andrezinia RA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(6):910-6. PubMed ID: 1217399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined use of metamizil and midantan in vascular parkinsonism].
    Kamenetskiĭ VK
    Klin Med (Mosk); 1979 Sep; 57(9):59-62. PubMed ID: 491516
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J; Raymondeaud C; Piot C
    Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
    [No Abstract]   [Full Text] [Related]  

  • 20. The L-dopa sparing effect of G 31,406 in the treatment of parkinson's disease.
    Couto B; Oliveira C; Mattos JP; Freitas MR
    Neurol Neurocir Psiquiatr; 1976; 17(4):285-92. PubMed ID: 798128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.